2-Aminoadipic acid is a biomarker for diabetes risk - Test2 - elhamkhani - TriplyDB

2-Aminoadipic acid is a biomarker for diabetes risk

2-Aminoadipic acid is a biomarker for diabetes risk

http://www.wikidata.org/entity/Q24617890

about

Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application Defining the metabolome: size, flux, and regulation Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study Metabolomics and diabetes: analytical and computational approaches Chemical Isotope Labeling LC-MS for Monitoring Disease Progression and Treatment in Animal Models: Plasma Metabolomics Study of Osteoarthritis Rat Model Changes in the Metabolome in Response to Low-Dose Exposure to Environmental Chemicals Used in Personal Care Products during Different Windows of Susceptibility Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis.Evaluation of the effects of L-carnitine on medaka (Oryzias latipes) fatty liver.Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes.Long term conservation of human metabolic phenotypes and link to heritability.Multilayered genetic and omics dissection of mitochondrial activity in a mouse reference population.Glyoxylate, a new marker metabolite of type 2 diabetes.Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.Impact of nutrient excess and endothelial nitric oxide synthase on the plasma metabolite profile in mice.High insulin combined with essential amino acids stimulates skeletal muscle mitochondrial protein synthesis while decreasing insulin sensitivity in healthy humans.Distinct metabolomic signatures are associated with longevity in humans.Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.A novel test for IGT utilizing metabolite markers of glucose tolerance.A systems view of type 2 diabetes-associated metabolic perturbations in saliva, blood and urine at different timescales of glycaemic control Dimethylglycine Deficiency and the Development of Diabetes.Effect of insulin sensitizer therapy on amino acids and their metabolites.Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis.Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study Comparative Circadian Metabolomics Reveal Differential Effects of Nutritional Challenge in the Serum and Liver Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People Lipidomic risk score independently and cost-effectively predicts risk of future type 2 diabetes: results from diverse cohorts Metabolomics: an emerging but powerful tool for precision medicine Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals.Postprandial Levels of Branch Chained and Aromatic Amino Acids Associate with Fasting Glycaemia Obesity-related metabolite profiles of black women spanning the epidemiologic transition.Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation.Profiling of plasma metabolites in postmenopausal women with metabolic syndrome Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.Metabolite Profiles Predict Acute Kidney Injury and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement.Perturbational Profiling of Metabolites in Patient Fibroblasts Implicates α-Aminoadipate as a Potential Biomarker for Bipolar Disorder.Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training Defects in muscle branched-chain amino acid oxidation contribute to impaired lipid metabolism Introduction to personalized medicine in diabetes mellitus.

P2860

Q26774386-4A3C316E-6FFC-4B7C-92CE-17FC71C1D7CD Q26865192-6E566D4A-3CDD-4299-B428-00C8987002FC Q27312512-0316F608-F74C-4281-ACB5-6BB31A6D6D60 Q28084835-AA429C3C-B46D-46CB-9344-2811C92D3695 Q28468330-D7526270-D7B3-403E-B3BB-BBF380E2AAC0 Q28553183-F97DEAA5-7B2C-4EFA-A8EE-137A1565498D Q33631151-551C84CE-2392-46F6-8625-E156C454B474 Q33766037-666CDA83-78B1-4DF8-82A9-8628DE2CBF9A Q33887865-D9925A0F-EA51-443E-B7BC-487307B3CA72 Q34073453-4A7539FF-16D8-4645-82D3-B92AE2D400ED Q34091261-4A4DF37F-E374-4F99-B5DC-1CB131994F8A Q34266060-1C18E818-D19D-4F06-8DF6-3CEB112571AD Q34454800-A41E69B9-605D-4794-92DB-9273FF5515FB Q34527732-B733730C-BA62-4494-955D-9C71FAFC4F34 Q34569354-4C8228D8-D705-4A20-8BC2-D498102EB496 Q34628283-0E1895CF-F3ED-4544-82FB-8C45718A7C1E Q35411463-87D5C9D7-4623-4BAF-A37F-FEC4D54D78C0 Q35534297-64CB9206-63D8-4475-91D0-3B338ED0231E Q35830440-5779BC07-1D8A-4D6F-85D3-208493CA178E Q35842441-7D9F4874-0A0B-4721-AD64-B1197D331300 Q35881734-91BFA98B-79FF-4493-8D65-F31F72E5AB39 Q35918756-3D0C646D-99EB-46A8-8A9D-9F3D8DA42B03 Q35919864-EE597652-F039-4EA6-9D99-0F7CDABFA042 Q35996543-4741A25F-4D4C-4049-AD22-4447B2279E13 Q36051943-B90A22DD-321A-4E33-9EC7-D46AD91DBE5B Q36548377-009F8CCC-374F-4DD1-A90F-94C79A973D95 Q36716070-52209692-BBF6-4232-B731-6D249B195B62 Q36765489-6086676B-122B-4A06-9E6E-6636FFAFA14E Q36851433-74B75AF3-8764-4B27-A9A8-1047F1E856D0 Q36895715-33084520-2F98-4A59-A23C-46634D31DE5F Q36914277-B5EB4D29-6EE9-4297-83DF-DB653CB0A106 Q37025089-E0BB13AC-4E32-435F-9C80-B229BC0DC240 Q37040183-B9094842-9D70-4FE1-9E5E-56C4FC4596E8 Q37052539-564A987C-59F5-436B-B8D9-AC2E9F1770C8 Q37070820-7667F859-65A2-4A15-A914-4F4310B1E310 Q37090726-ECE16A3C-04CA-4C80-8E0E-FDA43B0F383F Q37200180-DF09D519-451F-4234-A5F4-8DEF8DDB3F6C Q37213203-470DEF5F-E131-42CF-BF03-08E76D35DC81 Q37278842-7B8420FE-02A1-4764-97FD-93AFDAD66742 Q37523745-9DAF2F62-928A-4CD0-A98E-29376AD534C6

P2860

2-Aminoadipic acid is a biomarker for diabetes risk

http://www.wikidata.org/entity/Q24617890

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

2-Aminoadipic acid is a biomarker for diabetes risk

@ast

2-Aminoadipic acid is a biomarker for diabetes risk

@en

2-Aminoadipic acid is a biomarker for diabetes risk

@nl

type

label

2-Aminoadipic acid is a biomarker for diabetes risk

@ast

2-Aminoadipic acid is a biomarker for diabetes risk

@en

2-Aminoadipic acid is a biomarker for diabetes risk

@nl

prefLabel

2-Aminoadipic acid is a biomarker for diabetes risk

@ast

2-Aminoadipic acid is a biomarker for diabetes risk

@en

2-Aminoadipic acid is a biomarker for diabetes risk

@nl

P1433

Q24617890-ED316922-E3D7-47AD-8F97-F145506A3E8A

P1476

Q24617890-1D746A6A-2456-47BA-9BBC-C512F257790B

P2093

Q24617890-00ED1DC9-66E5-441E-A9DA-90F3B70B3A71

Q24617890-0B6CDDE9-2BBD-471D-B5B0-CA7B9E65608A

Q24617890-10B97592-E186-42C0-A4F1-34C07B6A3176

Q24617890-17E9B673-96FA-4FA3-A5D8-86B8C92FADF5

Q24617890-1A4C5CD6-9FAA-43EC-BCA9-0608F2B5290F

Q24617890-33DB6521-8168-45C1-81F3-CB8BEBC38EDD

Q24617890-39BB0190-FC02-4A08-AB0C-92038666E192

Q24617890-427BE546-E4AC-4396-99F4-AFADF65565E1

Q24617890-4311573E-E31C-47D1-B4B7-A2B2955D28FE

Q24617890-64545B3B-B5CB-49F7-AF45-9D824E4425B4

P2860

Q24617890-08892873-AF7C-4663-A0BE-21EC1A2A8F89

Q24617890-20F360DD-1809-4AD9-82BC-0ABE9865AD28

Q24617890-2CC11DAB-E4DA-4542-A511-23F57DC0B578

Q24617890-2F659D9A-A44A-4CBF-884B-E840D62B52D2

Q24617890-2F6A8DB7-04AC-4FA8-8B87-316A3F1DFE8C

Q24617890-33F8A628-F771-41AC-A845-23F8FCEDFB3A

Q24617890-3D3CBDCC-0DAF-456D-B5CB-20ABE6F0A9F7

Q24617890-41DD6C56-1CE0-44B4-97FE-4BB1E97AFAAE

Q24617890-4CE6C88E-FE7B-495C-BC64-014AEB0A1766

Q24617890-4F8C1514-E747-4C22-A628-9C23C9C0F746

P304

Q24617890-C2E19DB3-7943-45CC-A3FB-69690E51BE5D

P31

Q24617890-0FDE12CB-6E8B-4629-A8CD-40EAE5CFD2C1

P3181

Q24617890-A39F20CD-9D6C-4080-86A4-D9884ACCF11B

P356

Q24617890-35371116-E68E-48F0-B131-B805D688FD84

P407

Q24617890-8D727DB5-116F-4A99-9930-8A7D3265A5A6

P433

Q24617890-3DE4732F-E0D9-49B8-BBA5-69D581ACF47A

P478

Q24617890-CFE2E344-43D7-4A8B-B532-C880F0CFF229

P50

Q24617890-1CF84B5F-456D-48C9-BBCE-298D05842752

Q24617890-2A3D2A49-D1EE-4343-9CD4-C89E24BDA367

Q24617890-2E012DF6-215D-4A65-A44B-5929768C45C8

Q24617890-C4D1E4FE-BA76-4DED-B473-0D4A67D98817

Q24617890-D8C760D2-2FF0-4443-8950-E48F3210D9F8

P577

Q24617890-B612C97E-5A85-4FC5-A471-13DB8A800480

P5875

Q24617890-9E258184-917B-451C-918A-64628B1FA858

P698

Q24617890-7E38BF8D-6622-4833-B1B0-238A02689CF8

P921

Q24617890-037C467F-31DA-4662-9C90-0586092B620C

P932

Q24617890-085DD358-E4FB-49A6-8450-B7DAE5C79EBF

P3181

P356

P1433

Journal of Clinical Investigation

P1476

2-Aminoadipic acid is a biomarker for diabetes risk

@en

P2093

Amanda L Souza

http://www.w3.org/2001/XMLSchema#string

Anahita Ghorbani

http://www.w3.org/2001/XMLSchema#string

Andre Dejam

http://www.w3.org/2001/XMLSchema#string

Caroline S Fox

http://www.w3.org/2001/XMLSchema#string

Christian Carter

http://www.w3.org/2001/XMLSchema#string

Christopher J O'Donnell

http://www.w3.org/2001/XMLSchema#string

Clary B Clish

http://www.w3.org/2001/XMLSchema#string

Debby Ngo

http://www.w3.org/2001/XMLSchema#string

Elizabeth McCabe

http://www.w3.org/2001/XMLSchema#string

Eugene P Rhee

http://www.w3.org/2001/XMLSchema#string

P2860

Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance

Human metabolic individuality in biomedical and pharmaceutical research

Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

Metabolite profiles and the risk of developing diabetes

P304

4309-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

822690

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI64801

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Ramachandran S. Vasan

Nikolaos Psychogios

Martin Magnusson

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257348968

http://www.w3.org/2001/XMLSchema#string

P698

24091325

http://www.w3.org/2001/XMLSchema#string

P921

P932

3784523

http://www.w3.org/2001/XMLSchema#string